Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways

Journal of Experimental Medicine

Volumn 188, Issue 5, 1998, Pages 833-844

  Satterthwaite, Anne B ^a   Lowell, Clifford A ^b   Khan, Wasif N ^c,f   Sideras, Paschalis ^d   Alt, Frederick W ^c   Witte, Owen N ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UMEÅ UNIVERSITY   (Sweden)

^e MacDonald Research Laboratories (MRL)   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell development; B cell receptor; Immunodeficiency; Src family kinases; Transgenic mice

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; LYMPHOPOIESIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

AGAMMAGLOBULINEMIA; ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULINS; LYMPHOCYTE COUNT; LYMPHOPENIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 0032494195     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.5.833     Document Type: Article

References (60)

1. Goodnow, C.C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA. 93:2264-2271.
2. DeFranco, A.L. 1997. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:296-308.
3. Gong, S., and M.C. Nussenzweig. 1996. Regulation of an early developmental checkpoint in the B cell pathway by Igβ. Science. 272:411-414.
4. Torres, R.M., H. Flaswinkel, M. Reth, and K. Rajewsky. 1996. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science. 272:1804-1808.
5. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the iminunoglobulin μ chain gene. Nature. 350:423-426.
6. Kitamura, D., A. Kudo, S. Schaal, W. Muller, F. Melchers, and K. Rajewsky. 1992. A critical role of lambda 5 protein in B cell development. Cell. 69:823-831.
7. Cheng, A.M., B. Rowley, W. Pao, A. Hayday, J.B. Bolen, and T. Pawson. 1995. Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 378:303-306.
8. Turner, M., P.J. Mee, P.S. Costello, O. Williams, A.A. Price, L.P. Duddy, M.T. Furlong, R.L. Geahlen, and V.L. Tybulewicz. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 378: 298-302.
9. Kerner, J.D., M.W. Appleby, R.N. Mohr, S. Chien, D.J. Rawlings, C.R. Maliszewski, O.N. Witte, and R.M. Perlmutter. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 3:301-312.
10. Khan, W.N., F.W. Alt, R.M. Gerstein, B.A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A.B. Kantor, L.A. Herzenberg, et al. 1995. Defective B-cell development and function in Btk-deficient mice. Immunity. 3:283-299.
11. Hendriks, R.W., M.F. de Bruijn, A. Maas, G.M. Dingjan, A. Karis, and F. Grosveld. 1996. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO (Eur. Mol. Biol. Organ.) J. 15:4862-4872.
12. Hibbs, M.L., D.M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S.A. Stacker, and A.R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 83:301-311.
13. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in Lyn-deficient mice. Immunity. 3:549-560.
14. Chan, V.W., F. Meng, P. Soriano, A.L. DeFranco, and C.A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity. 7:69-81.
15. T in interleukin-5 receptor signaling. J. Exp. Med. 182: 811-820.
16. fyn-/-mice. J. Leukocyte Biol. 56:812-816.
17. Leitges, M., C. Schmedt, R. Guinamard, J. Davoust, S. Schaal, S. Stabel, and A. Tarakhovsky. 1996. Immunodeficiency in protein kinase Cβ-deficient mice. Science. 273: 788-791.
18. Tarakhovsky, A., M. Turner, S. Schaal, P.J. Mee, L.P. Duddy, K. Rajewsky, and V.L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 374:467-470.
19. Zhang, R., F.W. Alt., L. Davidson, S.H. Orkin, and W. Swat. 1995. Defective signaling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav protooncogene. Nature. 374:470-473.
20. Wang, J., T. Koizumi, and T. Watanabe. 1996. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184:831-838.
21. Cyster, J.G., and C.C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B cells and determines thresholds for negative selection. Immunity. 2:13-24.
22. Rawlings, D.J., A.M. Scharanberg, H. Park, M.I. Wahl, S. Lin, R.M. Kato, A.C. Fluckiger, O.N. Witte, and J.P. Kinet. 1996. Activation of Btk by a phosphorylation mechanism initiated by Src family kinases. Science. 271:822-825.
23. Mahajan, S., J. Fargnoli, A.L. Burkhardt, S.A. Kut, S.J. Saouaf, and J.B. Bolen. 1995. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol. Cell. Biol. 15:5304-5311.
24. Wahl, M.I., A.C. Fluckiger, R.M. Kato, H. Park, O.N. Witte, and D.J. Rawlings. 1997. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc. Natl. Acad. Sci. USA. 94:11526-11533.
25. Li, T., S. Tsukada, A. Satterthwaite, M.H. Havlik, H. Park, K. Takatsu, and O.N. Witte. 1995. Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin hoxmology (PH) domain. Immunity. 2:451-460.
26. Afar, D.E., H. Park, B.W. Howell, D.J. Rawlings, J. Cooper, and O.N. Witte. 1996. Regulation of Btk by Src family tyrosine kinases. Mol. Cell. Biol. 16:3465-3471.
27. 2+ following B cell receptor activation. EMBO (Eur. Mol. Biol. Organ.) J. 17:1973-1985.
28. Kurosaki, T., and M. Kurosaki. 1997. Transphosphorylation of Bruton's tyrosine kinase on tyrosine Y551 is critical for B cell antigen receptor function. J. Biol. Chem. 272:15595-15598.
29. Tsukada, S., D.C. Saffran, D.J. Rawlings, O. Parolini, R.C. Allen, I. Klisak, R.S. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 72:279-290.
30. Vetrie, D., I. Vorechovsky, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarstrom, C. Kinnon, R. Levinsky, M. Bobrow, et al. 1993. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature. 361:226-233.
31. Rawlings, D.J., D.C. Saffran, S. Tsukada, D.A. Largaespada, J.C. Grimaldi, L. Cohen, R.N. Mohr, J.F. Bazan, M. Howard, N.G. Copeland, et al. 1993. Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient xid mice. Science. 261:358-361.
32. Thomas, J.D., P. Sideras, C.I.E. Smith, I. Vorechovsky, V. Chapman, and W.E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 261:355-358.
33. Satterthwaite, A.B., and O.N. Witte. 1996. Lessons from human genetic variants in the study of B-cell differentiation. Curr. Opin. Immunol. 8:454-458.
34. Satterthwaite, A.B., H. Cheroutre, W.N. Khan, P. Sideras, and O.N. Witte. 1997. Btk dosage determines sensitivity to B cell antigen receptor crosslinking. Prof. Natl. Acad. Sci. USA. 94:13152-13157.
35. Pani, G., K.A. Siminovitch, and C.J. Paige. 1997. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J. Exp. Med. 186:581-588.
36. Hartley, S.B., M.P. Cooke, D.A. Fulcher, A.W. Harris, S. Cory, A. Basten and C.C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell. 72:325-335.
37. Bona, C., J.J. Mond, and W.E. Paul. 1980. Synergistic genetic defect in B lymphocyte function. I. Defective responses to B cell stimulants and their genetic basis. J. Exp. Med. 151: 224-234.
38. Bykowsky, M.J., R.N. Haire, Y. Ohta, H. Tang, S.S. Sung, E.S. Veksler, J.M. Greene, S.M. Fu, G.W. Littman, and K.E. Sullivan. 1996. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am. J. Hum. Genet. 58:477-483.
39. Taurog, J.D., H.M. Moutsopoulos, Y.J. Rosenberg, T.M. Chused, and A.D. Steinberg. 1979. CBA/N X-linked B cell defect prevents NZB B cell hyperactivity in F1 mice. J. Exp. Med. 150:31-43.
40. 1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J. Clin. Invest. 70:587-597.
41. Scribner, C.L, C.T. Hansen, D.M. Klinman and A.D. Steinberg. 1987. The interaction of the xid and me genes. J. Immunol. 138:3611-3617.
42. Hayakawa, K., R.R. Hardy, M. Honda, L.A. Herzenberg, A.D. Steinberg, and L.A. Herzenberg. 1984. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. USA. 81: 2494-2498.
43. Murakami, M., H. Yoshioka, T. Shirai, T. Tsubata, and T. Honjo. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7:877-882.
44. Hata, D., Y. Kawakami, N. Inagaki, C.S. Lantz, T. Kitamura, W.N. Khan, M. Maeda-Yamamoto, T. Miura, W. Han, S.E. Hartman, et al. 1998. Involvement of Bruton's tyrosine kinase in Fc(Square original of)RI-dependent mast cell degranulation and cytokine production. J. Exp. Mal. 187:1235-1247.
45. Fulcher, D.A., and A. Basten. 1997. Influences on the life span of B cell subpopulations defined by different phenotypes. Eur. J. Immunol. 27:1188-1199.
46. Lam, K.-P., R. Kuhn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 90:1073-1083.
47. Liao, X.C., D.R. Littman, and A. Weiss. 1997. Itk and Fyn make independent contributions to T cell activation. J. Exp. Med. 186:2069-2073.
48. Oka, Y., A. G. Rolink, J. Andersson, M. Kamanaka, J. Uchida, T. Yasui, T. Kishimoto, H. Kikutani, and F. Melchers. 1996. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int. Immunol. 8:1675-1685.
49. Khan, W.N., A. Nilsson, E. Mizoguchi, E. Castigli, J Forsell, A.K. Bhan, R. Geha, P. Sideras, and F.W. Alt. 1997. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int. Immunol. 9:395-405.
50. Renshaw, B.R., W.C. Fanslow III, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
51. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
52. Castigli, E., F.W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A.K. Bhan, and R.S. Geha. 1994. CD40-deficient mice grated by recombination-activating-gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91: 12135-12139.
53. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994 Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature. 371:389-395.
54. Takata, M., and T. Kurosaki. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184:31-40.
55. Brorson, K., M. Brunswick, S. Ezhevsky, D.G. Wei, R. Berg, D. Scott, and K.E. Stein. 1997. Xid affects events leading to B cell cycle entry. J. Immunol. 159:135-143.
56. Dorshkind, K., G.M. Keller, R.A. Phillips, R.G. Miller, G.C. Bosma, M. O'Toole, and M.J. Bosma. 1984. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J. Immunol. 132:1804-1808.
57. Hitoshi, Y., E. Sonoda, Y. Kikuchi, S. Yonehara, H. Nakauchi, and K. Takatsu. 1993. IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int. Immunol. 5:1183-1190.
58. Koike, M., Y. Kikuchi, A. Tominaga, S. Takaki, K. Akagi, J. Miyazaki, K. Yamamura, and K. Takatsu. 1995. Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice. Int. Immunol. 7:21-30.
59. Matsuda, T., M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mano, H. Hirai, O.N. Witte, and T. Hirano. 1995. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood. 85:627-633.
60. Go, N.F., B.E. Castle, R. Barrett, R. Kastelein, W. Dang, T.R. Mosmann, K.W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625-1631.